65615-22-7

Basic information

• Product Name: 3H-2-Benzopyran-3-one, 1,4-dihydro-8-hydroxy-7-(phenylmethoxy)-
• CAS NO: 65615-22-7
• Molecular Formula: C16H14O4
• Molecular Weight: 270.285
• Mol File: 65615-22-7.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: 3H-2-Benzopyran-3-one, 1,4-dihydro-8-hydroxy-7-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: 3H-2-Benzopyran-3-one, 1,4-dihydro-8-hydroxy-7-(phenylmethoxy)-(65615-22-7)
• EPA Substance Registry System: 3H-2-Benzopyran-3-one, 1,4-dihydro-8-hydroxy-7-(phenylmethoxy)-(65615-22-7)

Safety Data

• Hazardous Substances Data: 65615-22-7(Hazardous Substances Data)

Upstream product

• 5884-48-0 2-(4-(benzyloxy)-3-bromophenyl)acetic acid 
• 101111-25-5 methyl 2-(4-(benzyloxy)-3-bromophenyl)acetate 
• 34918-57-5 methyl 3-bromo-4-hydroxyphenylacetate 
• 14199-15-6 Methyl 4-hydroxyphenylacetate 
• 50-00-0 formaldehyd 
• 28988-68-3 2-(4-(benzyloxy)-3-hydroxyphenyl)acetic acid 

Downstream Products

• 65615-23-8 7-(benzyloxy)-8-methoxy-1H-isochromen-3(4H)-one 
• 16562-14-4 (-)-stepholidine 
• 16562-13-3 (+)-Stepholidine 
• 1258935-42-0 C₃₃H₃₄ClNO₄ 
• 1429118-76-2 C₃₃H₃₅NO₅ 
• 1429121-12-9 C₂₆H₂₇NO₅ 
• 1429118-84-2 C₂₇H₂₉NO₅ 
• 1415466-37-3 C₂₇H₂₉NO₄ 
• 1429118-86-4 C₃₃H₃₅NO₅ 
• 1429118-60-4 C₃₅H₃₇NO₆ 
• 1429118-66-0 C₂₈H₂₉NO₆ 
• 1429118-67-1 C₂₉H₃₁NO₆ 
• 1415466-36-2 C₂₉H₃₁NO₅ 
• 1429118-68-2 C₃₅H₃₇NO₆ 

Relevant articles and documents

Preparation method of isoquinoline alkaloid L-corydalmine

The invention belongs to the field of medical chemistry, and provides a preparation method of L-corydalmine or pharmaceutically acceptable salts thereof. The method comprises the following steps of: in the presence of an organic solvent, catalyzing by pal

DIARYL[A, G]QUINOLIZIDINE COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION, AND USES THEREOF

The present invention relates to a diarylo[a,g]quinolizidine compound of formula (I), enantiomer, diastereoisomer, racemate, mixture, pharmaceutically acceptable salt, crystalline hydrate or solvate thereof; the preparation method thereof, and uses thereof in preparing an experimental model drugs related to dopamine receptors and 5-HT receptors or a medicament for treating or preventing a disease related to dopamine receptors and 5-HT receptors.

HEXAHYDRODIBENZO[A,G]QUINOLIZINE COMPOUND, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION AND USE THEREOF

The present invention relates to a novel hexahydrodibenzo[a,g]quinoline compound represented by general formula (I) and its derivatives, enantiomer, diastereoisomer, raceme and mixtures thereof, as well as pharmaceutically acceptable salts thereof. The pr